TYR, tyrosinase, 7299

N. diseases: 281; N. variants: 121
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 GeneticVariation disease BEFREE At least four forms of OCA and one of OA are known, associated with TYR (OCA1), OCA2 (OCA2), TYRP1 (OCA3), SLC45A2 (OCA4) and GPR143 (OA1) loci, respectively. 23668539 2013
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 Biomarker disease BEFREE Those genes include agouti signalling protein (ASIP), tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), oculocutaneous albinism II (OCA2), various solute carrier genes and transporters. 20601102 2010
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 GeneticVariation disease BEFREE Blood samples were collected from 23 probands and 13 affected family members from 23 genetically unrelated Indian families (22 diagnosed as OCA and 1 diagnosed as OA) and analyzed by bidirectional DNA sequencing of the classic OCA genes--tyrosinase (TYR, or oculocutaneous albinism IA), pink eyed dilution (P; or oculocutaneous albinism II (OCA2]), tyrosinase-related protein 1 (TYRP1), solute carrier family 45, member 2 (SLC45A2; or membrane-associated transporter protein [MATP])--and the OA1 gene, G protein-coupled receptor 143 (GPR143). 20806075 2010
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 Biomarker disease BEFREE Remarkably, this heterologous expression system recapitulates the defective processing and mistrafficking of tyrosinase observed in OCA2 albino melanocytes and certain amelanotic melanoma cells. 16199032 2006
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 Biomarker disease BEFREE Mutations within the P gene have also been associated with tyrosinase-positive (type II) oculocutaneous albinism. 7557977 1995
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 GeneticVariation disease BEFREE We studied the tyrosinase and P genes in three patients with type II oculocutaneous albinism, one of whom also had Prader-Willi syndrome, and in one patient with a milder syndrome known as autosomal recessive ocular albinism. 8302318 1994
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 Biomarker disease BEFREE In addition, we report a mutation in both copies of the human P gene in one case of tyrosinase-positive (type II) oculocutaneous albinism, recently linked to 15q11-q13 (ref.9). 8421497 1993
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 AlteredExpression disease BEFREE We therefore propose that the molecular basis for the development of tyrosinase-positive oculocutaneous albinism exists as a defect in other proteins required for the activation of tyrosinase or in other regions of the tyrosinase gene. 1498098 1992
CUI: C0268495
Disease: Oculocutaneous albinism type 2
Oculocutaneous albinism type 2
0.090 Biomarker disease BEFREE (1978) to also obtain a genetical classification, supported by the hairbulb test, has not proved to be useful for the classification of tyrosinase negative (TNOCA), tyrosinase positive oculocutaneous albinism (TPOCA), and autosomal recessive ocular albinism (AROA) as genetically distinct forms. 3109790 1987